YK
Yogendra Kumar Gupta
About Yogendra Kumar Gupta
Data last updated:
Yogendra Kumar Gupta is a Director at Cliantha Research Limited (since 2024), Director at Bharat Immunologicals And Biologicals Corporation Limited (since 2010) and Director at Foundation For Disease Elimination And Control Of India (since 2018), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹861 Cr; the largest is Cliantha Research Limited at ₹782 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Sep 2024 | 2004 | ₹782 Cr (FY 2026) | Active | |
| Director | 26 Oct 2010 | 1989 | ₹79.49 Cr (FY 2022) | Active | |
| Director | 04 Aug 2018 | 2016 | ₹13.4 Lakh (FY 2025) | Active | |
| Director | 01 Mar 2024 | 2018 | ₹8,800 (FY 2024) | Active | |
| Designated Partner | 16 Oct 2020 | 2020 | Active |
Board colleagues of Yogendra Kumar Gupta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogendra Kumar Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogendra Kumar Gupta
Yogendra Kumar Gupta currently holds 5 directorships: Cliantha Research Limited (Director, since 05 Sep 2024, revenue ₹782 Cr (FY 2026)); Bharat Immunologicals And Biologicals Corporation Limited (Director, since 26 Oct 2010, revenue ₹79.49 Cr (FY 2022)); Foundation For Disease Elimination And Control Of India (Director, since 04 Aug 2018, revenue ₹13.4 Lakh (FY 2025)); Sicuremi Healthcare Technologies Private Limited (Director, since 01 Mar 2024, revenue ₹8,800 (FY 2024)); Vatyka Health Vision Llp (Designated Partner, since 16 Oct 2020).
Yogendra Kumar Gupta was first appointed on 26 Oct 2010 as Director at Bharat Immunologicals And Biologicals Corporation Limited. The most recent appointment on record is 05 Sep 2024 at Cliantha Research Limited.
The 4 current companies of Yogendra Kumar Gupta that report revenue have a combined latest revenue of ₹861 Cr: Cliantha Research Limited ₹782 Cr (FY 2026); Bharat Immunologicals And Biologicals Corporation Limited ₹79.49 Cr (FY 2022); Foundation For Disease Elimination And Control Of India ₹13.4 Lakh (FY 2025); Sicuremi Healthcare Technologies Private Limited ₹8,800 (FY 2024).
The current boards of Yogendra Kumar Gupta's companies include Manubhai Khodidas Patel (Cliantha Research Limited), Naveen Sharma (Cliantha Research Limited), Naveen Sharma (Cliantha Research Limited), Nilima Arun Kshirsagar (Cliantha Research Limited), Rajiv Vikrambhai Kamani (Cliantha Research Limited), Alka Sharma (Bharat Immunologicals And Biologicals Corporation Limited), among others.